Citius Pharmaceuticals annual free cash flow
2017
2020
2021
Citius Pharmaceuticals Free Cash Flow (FCF) History (CTXR)
Citius Pharmaceuticals reported −$24.3M in free cash flow for fiscal 2021, a decrease of $7.3M from the previous fiscal year, with a free cash flow margin of −26952.61%.
View full Citius Pharmaceuticals company overviewCitius Pharmaceuticals free cash flow by year
| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2021 | 2021-09-30 | −$24.3M | −$7.3M | — | −26952.61% |
| 2020 | 2020-09-30 | −$16.9M | −$9.0M | — | −18813.88% |
| 2017 | 2017-09-30 | −$8.0M | — | — | −15946.66% |
Citius Pharmaceuticals quarterly free cash flow
No reported data
| Fiscal quarter | Period ended | Free cash flow | Change | YoY growth | FCF margin |
|---|
Citius Pharmaceuticals free cash flow growth trends
About the metric
What free cash flow means
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
Calculation and source
How free cash flow is calculated
TickerStat calculates free cash flow as SEC-reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review Citius Pharmaceuticals filings at SEC.gov ↗